Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies

A Catalano, D Iacopetta, J Ceramella, D Scumaci… - Molecules, 2022 - mdpi.com
Multidrug resistance is a leading concern in public health. It describes a complex phenotype
whose predominant feature is resistance to a wide range of structurally unrelated cytotoxic …

Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters

A Sajid, H Rahman, SV Ambudkar - Nature Reviews Cancer, 2023 - nature.com
Cancer cells frequently display intrinsic or acquired resistance to chemically diverse
anticancer drugs, limiting therapeutic success. Among the main mechanisms of this …

[HTML][HTML] Apoptosis deregulation and the development of cancer multi-drug resistance

CM Neophytou, IP Trougakos, N Erin, P Papageorgis - Cancers, 2021 - mdpi.com
Simple Summary Despite recent therapeutic advances against cancer, many patients do not
respond well or respond poorly, to treatment and develop resistance to more than one anti …

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance

JQ Wang, Y Yang, CY Cai, QX Teng, Q Cui, J Lin… - Drug Resistance …, 2021 - Elsevier
ATP-binding cassette (ABC) transporters mediate the ATP-driven translocation of structurally
and mechanistically distinct substrates against steep concentration gradients. Among the …

ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates

JQ Wang, ZX Wu, Y Yang, QX Teng… - Journal of Evidence …, 2021 - Wiley Online Library
The ATP‐binding cassette (ABC) transporter superfamily is one of the largest membrane
protein families existing in wide spectrum of organisms from prokaryotes to human. ABC …

Targeting Bcl-2 for cancer therapy

L Zhang, Z Lu, X Zhao - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
Apoptosis deficiency is one of the most important features observed in neoplastic diseases.
The Bcl-2 family is composed of a subset of proteins that act as decisive apoptosis …

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2

CP Wu, SH Hsiao, YS Wu - Drug Resistance Updates, 2023 - Elsevier
The overexpression of the human ATP-binding cassette (ABC) transporters in cancer cells is
a common mechanism involved in develo** multidrug resistance (MDR). Unfortunately …

Molecular modeling strategies of cancer multidrug resistance

G Yalcin-Ozkat - Drug Resistance Updates, 2021 - Elsevier
Cancer remains a leading cause of morbidity and mortality worldwide. Hence, the increase
in cancer cases observed in the elderly population, as well as in children and adolescents …

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

HL Gao, Q Cui, JQ Wang, CR Ashby Jr… - Frontiers in …, 2023 - frontiersin.org
Introduction: The overexpression of ATP-binding cassette (ABC) transporters, ABCB1 and
ABCG2, are two of the major mediators of multidrug resistance (MDR) in cancers. Although …

Erdafitinib antagonizes ABCB1-mediated multidrug resistance in cancer cells

W Feng, M Zhang, ZX Wu, JQ Wang, XD Dong… - Frontiers in …, 2020 - frontiersin.org
ABCB1 overexpression is known to contribute to multidrug resistance (MDR) in cancers.
Therefore, it is critical to find effective drugs to target ABCB1 and overcome MDR. Erdafitinib …